Alerus Financial
XBI icon

Alerus Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alerus Financial’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.14K Sell
58
-82
-59% -$12.9K ﹤0.01% 411
2026
Q2 		$22.2K Hold
140
– – ﹤0.01% 343
2026
Q1 		$17.9K Hold
140
– – ﹤0.01% 353
2025
Q4 		$17.1K Hold
140
– – ﹤0.01% 310
2025
Q3 		$14K Sell
140
-70
-33% -$6.3K ﹤0.01% 347
2025
Q2 		$17.4K Buy
+210
New +$16.8K ﹤0.01% 317
2024
Q4 		– Sell
-34,314
Closed -$3.39M – 168
2024
Q3 		$3.39M Sell
34,314
-346
-1% -$34K 0.25% 81
2024
Q2 		$3.21M Sell
34,660
-137
-0.4% -$12.3K 0.24% 77
2024
Q1 		$3.3M Sell
34,797
-56
-0.2% -$5.2K 0.25% 83
2023
Q4 		$3.11M Sell
34,853
-19,802
-36% -$1.47M 0.25% 82
2023
Q3 		$3.99M Buy
54,655
+349
+0.6% +$27.9K 0.35% 71
2023
Q2 		$4.52M Buy
54,306
+954
+2% +$79.8K 0.38% 74
2023
Q1 		$4.07M Sell
53,352
-19,419
-27% -$1.61M 0.36% 77
2022
Q4 		$6.04M Buy
72,771
+2,600
+4% +$210K 0.55% 53
2022
Q3 		$5.57M Buy
70,171
+31,937
+84% +$2.69M 0.55% 46
2022
Q2 		$2.84M Buy
+38,234
New +$2.87M 0.26% 87
2022
Q1 		– Sell
-2,378
Closed -$266K – 191
2021
Q4 		$266K Sell
2,378
-27,009
-92% -$3.26M 0.02% 169
2021
Q3 		$3.69M Buy
29,387
+1,571
+6% +$202K 0.34% 77
2021
Q2 		$3.77M Buy
27,816
+272
+1% +$35.8K 0.38% 68
2021
Q1 		$3.74M Buy
27,544
+6,487
+31% +$971K 0.39% 71
2020
Q4 		$2.96M Buy
21,057
+833
+4% +$107K 0.3% 86
2020
Q3 		$2.25M Buy
20,224
+9,520
+89% +$1.07M 0.25% 95
2020
Q2 		$1.2M Buy
10,704
+729
+7% +$71.8K 0.14% 109
2020
Q1 		$772K Buy
9,975
+91
+0.9% +$8.06K 0.11% 111
2019
Q4 		$940K Buy
9,884
+120
+1% +$10.4K 0.11% 108
2019
Q3 		$745K Buy
+9,764
New +$811K 0.1% 110
2019
Q1 		– Sell
-18,138
Closed -$1.3M – 154
2018
Q4 		$1.3M Buy
+18,138
New +$1.46M 0.2% 94

Other funds holding XBI

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Employees Retirement System of Texas
Employees Retirement System of Texas Austin, Texas $12.2B AUM 27.55% 1-Year Est. Return
Investure LLC
Investure LLC Charlottesville, Virginia $1.83B AUM 14.32% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Alerus Financial's XBI Position: Q3 2026 in Review

Alerus Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 59% in Q3 2026, selling an estimated $12.9K and leaving 58 shares worth $9.14K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

Alerus Financial first reported a position in XBI in Q4 2018 and has held it in 27 quarters since. The position peaked at $6.04M in Q4 2022. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Alerus Financial held 58 shares of State Street SPDR S&P Biotech ETF worth $9.14K as of Q3 2026.
  • Alerus Financial sold 82 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $12.9K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Alerus Financial's portfolio in Q3 2026, its #411 holding.
  • Alerus Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 27 quarters since.
  • Alerus Financial's State Street SPDR S&P Biotech ETF position peaked at $6.04M in Q4 2022.
  • 604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Alerus Financial's 13F filing for Q3 2026, filed 9 Nov 2026.